Not checked for notices yet.
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
Kevin P Nishimoto, Taylor Barca, Aruna Azameera and 25 more
Clinical & Translational Immunology · 2022
Cited by papers we hold 5
- Exploiting innate immunity for cancer immunotherapy · 2023No notice
- Challenges and new technologies in adoptive cell therapy · 2023No notice
- γδ T cells: origin and fate, subsets, diseases and immunotherapy · 2023No notice
- CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies · 2023No notice
- Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.